Aziyo Partners with SurGenTec for Minimally Invasive Bone Graft Delivery

Biologics, Inc., a fully integrated regenerative medicine company,
announced today it has entered into a co-marketing agreement with
SurGenTec, a privately-owned medical device company based in Boca
Raton, FL. The Company will supply ViBone, its proprietary bone repair
product, to SurGenTec for marketing and distribution with its patented
GraftGun universal graft delivery system.

This press release features multimedia. View the full release here:

ViBone, a viable bone allograft produced by Aziyo Biologics, is now available for use with SurGenTec’s minimally invasive bone graft delivery system, GraftGun. The system is designed to allow for universal, quick and accurate bone graft delivery to a surgical site. (Graphic: Business Wire)

“As we continue to grow our portfolio of proprietary orthopedic surgery
products, innovative partnerships like this allow us to expand the reach
of our product marketing and distribution in a very rapid and efficient
way,” said Darryl Roberts, Ph.D., Executive Vice President and General
Manager, Musculoskeletal Products. “The GraftGun system is an optimal
device to deliver ViBone, enabling a next generation viable bone graft
to be easily delivered and used in challenging surgeries.”

This co-marketing agreement calls for Aziyo to provide its viable bone
matrix product, ViBone, to SurGenTec for use with the GraftGun System.
ViBone pre-filled cartridges will be marketed through the SurGenTec
distribution network.

Travis Greenhalgh, Founder and CEO of SurGenTec added, “Our Company is
focused on creating intuitive solutions to improve the quality of life
for patients. ViBone complements our GraftGun system by providing
surgeons and patients with a bone matrix product that is as close as
possible to the gold standard of autograft. This unique combination
offering of ViBone and GraftGun pre-filled cartridges will significantly
reduce time in the operating room.”

ViBone was launched in 2017 as a better option for bone repair
procedures. The advanced science and proprietary product processing was
designed for handling and clinical performance closer to that of
autograft. Similarly, SurGenTec’s patented GraftGun system was also
launched in 2017 with a focus on improving delivery of intraoperative
bone graft materials. Both products have been used in numerous
orthopedic procedures and continue to see strong market adoption.

About ViBone

ViBone is a next generation viable bone matrix that was designed to
perform and handle more like high quality autograft. The proprietary
manufacturing process was designed to optimally protect the tissue
environment with less disruption. ViBone is based on science that brings
bone grafting closer to meeting the surgeon and patient’s needs and
provides a better option for bone repair. To learn more about ViBone,

About GraftGun

GraftGun is part of SurGenTec’s Graft Delivery System (GDS). It is
designed to allow for universal, quick and accurate bone graft delivery
to a surgical site without the problems of a traditional funnel. Its
patented, controlled release method is designed to safely dispense bone
graft with enough pressure to easily fill any bone void during bone
graft surgery. The GraftGun GDS includes SurGenTec’s loading device
technology, which provides surgeons the freedom to choose the bone graft
that best suits their needs. To learn more about the GraftGun system,

About Aziyo
Biologics, Inc.

Aziyo Biologics is a fully integrated, commercially oriented
regenerative medicine company. Since its founding in 2015 the Company
has expanded through acquisitions and strategic partnerships, creating a
high growth commercial entity. Its proprietary products are used in
orthopedic, cardiovascular and other medical specialties. For more
information, visit

About SurGenTec,

SurGenTec is a privately-owned medical device company based out of Boca
Raton, FL that strives to bring the next level of technology to the
spine and orthopedic industry. SurGenTec develops and manufactures
innovative products with patient and surgeon safety at the heart of
everything they do. For more information, visit

View source version on

Leave a Comment